Earnings Feed
Start Free
Home/Insiders/CARLSSON CARL AKE
CC
SEC Insider//CIK 0001196060

CARLSSON CARL AKE

CIK 00011960601 companyHOVIK, Q8
SEC Profile

Transactions

37

Companies

1

Filings

3

CIK

0001196060

Recent Transactions

37 trades
  • Exercise/Conversion
    ALPHARMA INC

    Common Stock A

    2007-06-04$19.80/sh+2,275→ 24,421 total
  • Exercise/Conversion
    ALPHARMA INC

    Non-Qualified Stock Option (right to buy)

    2007-06-04$25.38/sh−400→ 3,375 total
  • Exercise/Conversion
    ALPHARMA INC

    Non-Qualified Stock Option (right to buy)

    2007-06-04$25.39/sh−2,275→ 3,775 total
  • Exercise/Conversion
    ALPHARMA INC

    Non-Qualified Stock Option (right to buy)

    2007-06-04$25.40/sh−700→ 6,050 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2007-06-04$25.38/sh−400→ 22,146 total
  • Exercise/Conversion
    ALPHARMA INC

    Common Stock A

    2007-06-04$19.80/sh+400→ 22,546 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2007-06-04$25.39/sh−2,275→ 22,146 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2007-06-04$25.42/sh−2,391→ 29,316 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2007-06-04$25.41/sh−100→ 29,216 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2007-06-04$25.40/sh−3,800→ 25,416 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2007-06-04$25.39/sh−100→ 25,316 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2007-06-04$25.38/sh−1,262→ 24,054 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2007-06-04$25.37/sh−1,908→ 22,146 total
  • Exercise/Conversion
    ALPHARMA INC

    Common Stock A

    2007-06-04$19.80/sh+700→ 22,846 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2007-06-04$25.40/sh−700→ 22,146 total
  • Exercise/Conversion
    ALPHARMA INC

    Non-Qualified Stock Option (right to buy)

    2007-01-29−6,250→ 0 total
  • Exercise/Conversion
    ALPHARMA INC

    Common Stock A

    2007-01-29$9.48/sh+6,250→ 12,015 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2007-01-29$27.00/sh−6,250→ 5,765 total
  • Exercise/Conversion
    ALPHARMA INC

    Non-Qualified Stock Option (right to buy)

    2006-03-17−18,750→ 6,250 total
  • Exercise/Conversion
    ALPHARMA INC

    Non-Qualified Stock Option (right to buy)

    2006-03-17−15,000→ 5,000 total
  • Exercise/Conversion
    ALPHARMA INC

    Non-Qualified Stock Option (right to buy)

    2006-03-17−6,750→ 6,750 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2006-03-17$27.09/sh−6,750→ 4,880 total
  • Exercise/Conversion
    ALPHARMA INC

    Common Stock A

    2006-03-17$14.44/sh+15,000→ 19,880 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2006-03-17$27.09/sh−15,000→ 4,880 total
  • Exercise/Conversion
    ALPHARMA INC

    Common Stock A

    2006-03-17$9.48/sh+18,750→ 23,630 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2006-03-17$27.09/sh−18,750→ 4,880 total
  • Exercise/Conversion
    ALPHARMA INC

    Common Stock A

    2006-03-17$19.80/sh+6,750→ 11,630 total
  • Award
    ALPHARMA INC

    Restricted Stock Unit

    2005-05-12+20,000→ 27,200 total
  • Other
    ALPHARMA INC

    Common Stock A

    2004-12-31+1,131→ 10,785 total
  • Award
    ALPHARMA INC

    Restricted Stock Unit

    2004-03-08+7,200→ 7,200 total
  • Other
    ALPHARMA INC

    Common Stock A

    2003-12-31+1,006→ 2,454 total
  • Exercise/Conversion
    ALPHARMA INC

    Non-Qualified Stock Option (right to buy)

    2003-09-17$20.22/sh−2,500→ 5,000 total
  • Exercise/Conversion
    ALPHARMA INC

    Common Stock A

    2003-09-17$9.48/sh+5,000→ 6,448 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2003-09-17$20.22/sh−2,500→ 1,448 total
  • Exercise/Conversion
    ALPHARMA INC

    Common Stock A

    2003-09-17$9.48/sh+2,500→ 3,948 total
  • Exercise/Conversion
    ALPHARMA INC

    Non-Qualified Stock Option (right to buy)

    2003-09-17$20.20/sh−5,000→ 0 total
  • Sale
    ALPHARMA INC

    Common Stock A

    2003-09-17$20.20/sh−5,000→ 1,448 total

Companies

1

Recent Filings

3

Address

BATSTOJORDET 93

HOVIK, Q8, 1322

View on SEC.gov